Area of research
Cardiology and Cardiovascular Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Ejection fraction and Heart failure, with related work in Empagliflozin, Intensive care medicine, Clinical trial. Notable publications include 'The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data', 'Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis', and 'Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?'.
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
Effect of Empagliflozin on Cardiovascular and Kidney Outcomes in Patients with Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis
The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?